CaP Biomaterials, LLC is an innovative company specializing in the manufacturing of calcium phosphates with a focus on meeting customized specifications. The company, founded in 2006 and headquartered in the United States, holds an ISO13485:2016 certification, adding credibility to its status as a contract manufacturer of calcium phosphate biomaterials for medical devices. CaP Biomaterials' commitment to quality is evident through its in-house analytical equipment, which includes dissolution and solubility testing, two spray dryers, large volume blending options, and multiple granulation processes. This comprehensive infrastructure enables the company to cater to diverse material requirements for medical applications. CaP Biomaterials' strong emphasis on collaboration is evident from its availability to assist during the research and development process. The company offers support to clients by providing sample materials manufactured on full-scale production equipment. The diverse applications of calcium phosphate biomaterials make the company relevant to a wide array of industries, including Biopharma, Biotechnology, and Manufacturing. As of now, there is no information available regarding the company's last investment or the last investment investors. However, the company's unique positioning in the biopharmaceutical and biotechnological manufacturing sector warrants attention from potential investors seeking opportunities in the medical materials space. CaP Biomaterials, with its expertise and capabilities, presents an intriguing investment prospect for those interested in cutting-edge advancements in medical device materials.
There is no investment information
No recent news or press coverage available for CaP Biomaterials, LLC.